Portman Square Capital’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-41,723
Closed -$13.1M 160
2025
Q2
$13.1M Sell
41,723
-16,911
-29% -$4.88M 0.38% 56
2025
Q1
$15.4M Buy
58,634
+9,620
+20% +$2.6M 0.41% 70
2024
Q4
$12.8M Buy
49,014
+9,516
+24% +$2.4M 0.46% 55
2024
Q3
$9.19M Sell
39,498
-4,641
-11% -$953K 0.34% 97
2024
Q2
$8.91M Buy
44,139
+8,644
+24% +$1.56M 0.31% 103
2024
Q1
$6.08M Buy
+35,495
New +$6.62M 0.17% 142
2023
Q4
Sell
-109,738
Closed -$18.8M 473
2023
Q3
$17.5M Buy
109,738
+26,793
+32% +$6M 0.43% 59
2023
Q2
$23.9M Buy
82,945
+155
+0.2% +$47.1K 0.68% 34
2023
Q1
$26.4M Buy
82,790
+7,886
+11% +$2.34M 1.21% 20
2022
Q4
$22.1M Buy
+74,904
New +$20.7M 1.63% 12

Other funds holding PODD

Portman Square Capital's PODD Position: Q3 2025 in Review

Portman Square Capital sold out of Insulet (PODD) in Q3 2025, closing a stake of 41,723 shares — an estimated $13.1M sold.

Portman Square Capital first reported a position in PODD in Q4 2022 and held it in 10 quarters. The position peaked at $26.4M in Q1 2023. 813 funds tracked by Wall St. Rank hold PODD as of Q3 2025.

  • Portman Square Capital reported no remaining Insulet position as of Q3 2025 after selling out during the quarter.
  • Portman Square Capital sold 41,723 Insulet shares in Q3 2025, an estimated $13.1M.
  • Portman Square Capital first reported a position in Insulet in Q4 2022 and held it in 10 quarters.
  • Portman Square Capital's Insulet position peaked at $26.4M in Q1 2023.
  • 813 funds tracked by Wall St. Rank held Insulet as of Q3 2025.

Based on Portman Square Capital's 13F filing for Q3 2025, filed 16 Oct 2025.